These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8246611)

  • 21. Post-remission therapy of adult acute myeloid leukemia: high dose cytosine-arabinoside versus other consolidation regimens.
    Zeremski V; Savić A
    Med Pregl; 2014; 67(3-4):83-90. PubMed ID: 24961049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 60 or 90 mg/m(2) of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics.
    Devillier R; Bertoli S; Prébet T; Huguet F; Etienne A; Charbonnier A; Rey J; Delabesse E; D'Incan E; Huynh A; Blaise D; Récher C; Vey N
    Am J Hematol; 2015 Feb; 90(2):E29-30. PubMed ID: 25363834
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
    Fukushima T; Ueda T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-intensive treatment of acute myelogenous leukemia: improved survival?
    Schiller G
    J Clin Oncol; 1995 Jul; 13(7):1828-30. PubMed ID: 7602375
    [No Abstract]   [Full Text] [Related]  

  • 25. [Indications for allogeneic bone marrow transplantation (BMT) in adult acute myelogenous leukemia: matched-pair analysis in comparison with chemotherapy in patients achieving initial remission].
    Sakura T
    Rinsho Ketsueki; 2001 May; 42(5):380-4. PubMed ID: 11452455
    [No Abstract]   [Full Text] [Related]  

  • 26. Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).
    Niederwieser C; Nicolet D; Carroll AJ; Kolitz JE; Powell BL; Kohlschmidt J; Stone RM; Byrd JC; Mrózek K; Bloomfield CD
    Haematologica; 2016 Dec; 101(12):1516-1523. PubMed ID: 27470602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group (ECOG) experience.
    Bennett JM; Andersen JW; Cassileth PA
    Leuk Res; 1991; 15(4):223-7. PubMed ID: 2030603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of clinical remission and survival between CLAG and FLAG induction chemotherapy in patients with refractory or relapsed acute myeloid leukemia: a prospective cohort study.
    Bao Y; Zhao J; Li ZZ
    Clin Transl Oncol; 2018 Jul; 20(7):870-880. PubMed ID: 29181696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of adult acute myelogenous leukemia in first complete remission.
    Collisson EA; Lashkari A; Malone R; Paquette R; Emmanouilides C; Territo MC; Schiller GJ
    Leukemia; 2003 Nov; 17(11):2183-8. PubMed ID: 12931210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia.
    Girmenia C; Micozzi A; Piciocchi A; Gentile G; Di Caprio L; Nasso D; Minotti C; Capria S; Cartoni C; Alimena G; Meloni G; Amadori S; Foà R; Venditti A
    Leuk Res; 2014 Apr; 38(4):469-74. PubMed ID: 24534569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results and proposal standard for the indication of bone marrow transplantation in acute nonlymphocytic leukemia].
    Kodera Y
    Nihon Rinsho; 1990 Sep; 48(9):2080-6. PubMed ID: 2232213
    [No Abstract]   [Full Text] [Related]  

  • 32. Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL).
    Wiernik PH; Serpick AA
    Medicine (Baltimore); 1970 Nov; 49(6):505-13. PubMed ID: 5286084
    [No Abstract]   [Full Text] [Related]  

  • 33. Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group.
    Ifrah N; Witz F; Jouet JP; François S; Lamy T; Linassier C; Pignon B; Berthou C; Guyotat D; Cahn JY; Harousseau JL
    Cancer; 1999 Oct; 86(8):1496-505. PubMed ID: 10526278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate-risk karyotype in first complete remission.
    Hemmati PG; Terwey TH; Na IK; le Coutre P; Jehn CF; Vuong LG; Dörken B; Arnold R
    Eur J Haematol; 2015 May; 94(5):431-8. PubMed ID: 25220715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
    Walters RS; Kantarjian HM; Keating MJ; Plunkett WK; Estey EH; Andersson B; Beran M; McCredie KB; Freireich EJ
    Cancer; 1988 Aug; 62(4):677-82. PubMed ID: 3165047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission.
    Cortes JE; Kantarjian HM; O'Brien S; Giles F; Keating MJ; Freireich EJ; Estey EH
    Cancer; 1999 Apr; 85(7):1506-13. PubMed ID: 10193940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved survival for patients with acute myelogenous leukemia.
    Mitus AJ; Miller KB; Schenkein DP; Ryan HF; Parsons SK; Wheeler C; Antin JH
    J Clin Oncol; 1995 Mar; 13(3):560-9. PubMed ID: 7884416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients).
    Castaigne S; Chevret S; Lepage E; Guilhot F; Fenaux P; Bordessoule D; Tilly H; Auzanneau G; Tertian G; Guy H
    Nouv Rev Fr Hematol (1978); 1990; 32(5):297-300. PubMed ID: 2099400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 results.
    Quintana J; Advis P; Becker A; Beresi V; Campbell M; Vinés EF; García H; Salgado C; Vargas L; Rojas J; Obando M; Neira L; Páez E; Zolezzi P
    Leukemia; 2005 Dec; 19(12):2143-6. PubMed ID: 16304574
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapy versus transplants for acute myelogenous leukemia in second remission.
    Gale RP; Horowitz MM; Rees JK; Gray RG; Oken MM; Estey EH; Kim KM; Zhang MJ; Ash RC; Atkinson K; Champlin RE; Dicke KA; Gajewski JL; Goldman JM; Helbig W; Henslee-Downey PS; Hinterberger W; Jacobsen N; Keating A; Klein JP; Marmont AM; Prentice HG; Reiffers J; Rimm AA; Bortin MM
    Leukemia; 1996 Jan; 10(1):13-9. PubMed ID: 8558917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.